Vericel VCEL
NASDAQ VCEL
$38.99 -0.09 (-0.23%)
As of: Sep 9, 2026 · 3:59 PM EDT

Vericel (VCEL) Intangibles (2014 - 2026)

Vericel's (VCEL) quarterly Intangibles came in at $5.3 million in Q2 2026, down 10.53% year-over-year from $5.9 million in Q2 2025, and down 2.85% quarter-over-quarter from $5.5 million in Q1 2026.

Analysis

Vericel (VCEL) Intangibles (2014 - 2026) Analysis & Trends

Vericel has disclosed Intangibles across 8 years of filings, most recently posting $5.3 million for Q2 2026.

  • In Q2 2026, Intangibles fell 10.53% year-over-year to $5.3 million; the TTM figure through Jun 2026 stood at $5.3 million (down 10.53% YoY), while the FY2025 annual figure was $5.6 million, down 10.0% from the prior year.
  • Intangibles came in at $5.3 million for Q2 2026 at Vericel, down from $5.5 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $7.5 million in Q4 2022 to a low of $5.3 million in Q2 2026.
  • Average Intangibles over 5 years is $6.4 million, with a median of $6.4 million recorded in 2024.
  • Year-over-year, Intangibles slipped 8.33% in 2023 and decreased 10.53% in 2026.
  • Over 5 years, Intangibles stood at $7.5 million in 2022, then dropped by 8.33% to $6.9 million in 2023, then decreased by 9.09% to $6.2 million in 2024, then slipped by 10.0% to $5.6 million in 2025, then decreased by 5.55% to $5.3 million in 2026.
  • Per Business Quant data, the three most recent Intangibles figures were $5.3 million in Q2 2026, $5.5 million in Q1 2026, and $5.6 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn -
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn - -
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn 330.24 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn -
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn 62.10 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn - -
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn 2.55 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn 30.61 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn 5.31 Mn
10 Taysha Gene Therapies 1.97 Bn 1.97 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.31 Mn
Mar 31, 2026 5.47 Mn
Dec 31, 2025 5.63 Mn
Sep 30, 2025 5.78 Mn
Jun 30, 2025 5.94 Mn
Mar 31, 2025 6.09 Mn
Dec 31, 2024 6.25 Mn
Sep 30, 2024 6.41 Mn
Jun 30, 2024 6.56 Mn
Mar 31, 2024 6.72 Mn
Dec 31, 2023 6.88 Mn
Sep 30, 2023 7.03 Mn
Jun 30, 2023 7.19 Mn
Mar 31, 2023 7.34 Mn
Dec 31, 2022 7.50 Mn
Sep 30, 2016 2.71 Mn
Jun 30, 2016 2.78 Mn
Mar 31, 2016 2.85 Mn
Dec 31, 2015 2.92 Mn
Sep 30, 2015 2.99 Mn